CJ
NVO

Caitlin John’s Novo Nordisk NVO Stock Holding History

Caitlin John’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11K Buy
299
+7
+2% +$332 0.01% 508
2025
Q4 		$14.9K Buy
292
+262
+873% +$13.4K 0.01% 481
2025
Q3 		$1.68K Buy
+30
New +$1.76K ﹤0.01% 707
2025
Q1 		– Sell
-14
Closed -$1.22K – 577
2024
Q4 		$1.22K Hold
14
– – ﹤0.01% 714
2024
Q3 		$1.52K Hold
14
– – ﹤0.01% 689
2024
Q2 		$2.03K Hold
14
– – ﹤0.01% 652
2024
Q1 		$1.83K Sell
14
-176
-93% -$21K ﹤0.01% 689
2023
Q4 		$19.7K Buy
+190
New +$18.8K 0.02% 340

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Caitlin John's NVO Position: Q1 2026 in Review

Caitlin John increased its Novo Nordisk (NVO) stake by 2.4% in Q1 2026, buying an estimated $332 and bringing the position to 299 shares worth $11K. The position accounts for 0.01% of the portfolio, ranked #508.

Caitlin John first reported a position in NVO in Q4 2023 and has held it in 8 quarters since. The position peaked at $19.7K in Q4 2023. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Caitlin John held 299 shares of Novo Nordisk worth $11K as of Q1 2026.
  • Caitlin John bought 7 Novo Nordisk shares in Q1 2026, an estimated $332.
  • Novo Nordisk made up 0.01% of Caitlin John's portfolio in Q1 2026, its #508 holding.
  • Caitlin John first reported a position in Novo Nordisk in Q4 2023 and has held it in 8 quarters since.
  • Caitlin John's Novo Nordisk position peaked at $19.7K in Q4 2023.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Caitlin John's 13F filing for Q1 2026, filed 13 May 2026.